CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 88 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q4 2019. The put-call ratio across all filers is 0.32 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,089,000 | -7.8% | 9,200 | -8.0% | 0.01% | 0.0% |
| Q4 2020 | $1,181,000 | +62.7% | 10,000 | +53.1% | 0.01% | +25.0% |
| Q3 2020 | $726,000 | -20.1% | 6,530 | -26.6% | 0.00% | -33.3% |
| Q2 2020 | $909,000 | +68.3% | 8,900 | +78.0% | 0.01% | +50.0% |
| Q1 2020 | $540,000 | -54.1% | 5,000 | -50.5% | 0.00% | -50.0% |
| Q4 2019 | $1,176,000 | -28.7% | 10,100 | -29.9% | 0.01% | -42.9% |
| Q3 2019 | $1,650,000 | -59.6% | 14,416 | -66.4% | 0.01% | -61.1% |
| Q2 2019 | $4,089,000 | – | 42,900 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEW SILK ROAD INVESTMENT PTE LTD | 189,395 | $17,476,000 | 9.13% |
| VERNIER CAPITAL PARTNERS, LP | 122,600 | $11,312,000 | 8.31% |
| RUDMAN ERROL M | 26,901 | $2,482,000 | 1.42% |
| HERMES INVESTMENT MANAGEMENT LTD | 712,424 | $65,735,000 | 0.99% |
| Hillhouse Capital Management | 618,391 | $57,059,000 | 0.94% |
| COMGEST GLOBAL INVESTORS S.A.S. | 356,252 | $32,872,000 | 0.76% |
| CORNERSTONE CAPITAL MANAGEMENT HOLDINGS LLC. | 363,190 | $33,511,000 | 0.26% |
| FIL Ltd | 914,848 | $84,413,000 | 0.24% |
| Gideon Capital Advisors, Inc. | 2,494 | $230,000 | 0.23% |
| WASATCH ADVISORS LP | 137,482 | $12,685,000 | 0.17% |